Fexapotide Triflutate Induces Selective Prostate Glandular Pharmaco-Ablation in the Rat

INTRODUCTION: A clinical challenge for interventional prostate treatments for localized prostate cancer has been to elicit cancer tissue eradication which can avoid undesirable toxicities and irreparable damage to adjacent structures. Fexapotide triflutate (FT) has been shown in human clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Averback, Paul, Gohal, Rajna, Fuska, Marta, Prins, Kathleen, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929934/
https://www.ncbi.nlm.nih.gov/pubmed/31909043
http://dx.doi.org/10.2147/RRU.S231334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929934/
https://www.ncbi.nlm.nih.gov/pubmed/31909043
http://dx.doi.org/10.2147/RRU.S231334

Ejemplares similares